Endocrine disruption in the aging urothelium

老化尿路上皮的内分泌干扰

• 批准号: 8773226
• 负责人: Tiffani J Houston
• 金额: $ 6.35万
• 依托单位: UNIVERSITY OF TEXAS HLTH SCIENCE CENTER
• 依托单位国家: 美国
• 财政年份: 2014
• 资助国家: 美国
• 起止时间: 2014-09-15 至 2015-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8773226
• 关键词: Address; Age; Aging; Andropause; Angiopoietins; Animal Model; Apoptosis; Arsenic; Automobile Driving; Awareness; Behavioral; Binding Sites; Biological Assay; Bladder; Bladder Tissue; Cardiovascular system; Cell Line; Chronic; Chronic Disease; Complex; Data; Dexamethasone; Diabetes Mellitus; Diagnosis; Disease; Dose; Elderly; Electrophoresis; Electrophoretic Mobility Shift Assay; Endocrine; Endocrine Disruptors; Endocrine disruption; Endocrine system; Environment; Environmental Risk Factor; Epithelium; Event; Excision; Exposure to; Functional disorder; Glucocorticoid Receptor; Glucocorticoids; Health; Heavy Metals; Human; Human Development; Immunosuppression; Individual; Lead; Life; Link; Luciferases; Malignant Neoplasms; Malignant neoplasm of urinary bladder; Measures; Mediating; Menopause; Mentors; Modeling; Monitor; Mus; Muscle; Mutate; Mutation; Neurologic; Osteoporosis; Papillary Neoplasm; Patients; Pelvis; Physiological; Physiological Processes; Physiology; Population; Prevention; Process; Proteins; Quality of life; Radical Cystectomy; Receptor Activation; Receptor Gene; Recurrence; Reporter; Research Priority; Response Elements; Role; Solid Neoplasm; Testing; Thyroid Gland; Time; Tissues; Toxin; Transactivation; Transcriptional Regulation; Transfection; Urothelium; activating transcription factor; age related; aged; aging population; cancer therapy; carcinogenesis; chromatin immunoprecipitation; cost; disease characteristic; drinking water; effective therapy; epithelial to mesenchymal transition; expression vector; healthy aging; in vivo; innovation; lipid metabolism; mRNA Expression; metaplastic cell transformation; mutant; promoter; public health relevance; receptor expression; response; steroid hormone; steroid hormone receptor

DESCRIPTION (provided by applicant): Alterations of the endocrine system are well established in the aging population. Conditions that arise include diabetes, thyroid complications, osteoporosis, cardiovascular events, and cancer. Heavy metals, such as arsenic, are known endocrine disruptors and chronic exposure through drinking water is linked to a broad range of chronic diseases characteristic to the aging population, including cancer of the urinary bladder. Bladder cancer (BlCa) is a disease of the aging population with an average age of diagnosis at 73 years. BlCa has one of the highest recurrence rates of all solid tumors and the treatment course has a significant effect on quality of life. 20 percent of patients have recurrence of papillary tumors following surgical removal and require frequent surveillance. Furthermore, patients with muscle invasive disease have pelvic recurrence seven to eight months after radical cystectomy. BlCa has a morbid disease process and costs the US 3 billion dollars per year. Furthermore, the majority of patients that lose their lives to BlCa have undergone curative treatment that ultimately fails. Poor understanding of the pathophysiology of BlCa contributes to the lack of effective treatment and also makes it difficult to develop preventative measures to ultimately promote healthy aging. This is important to consider because in less than 50 years, over 25 percent of the US population will be over the age of 65 years. BlCa is most commonly induced by chronic exposure to environmental risk factors throughout life, such as arsenic. Arsenic modulates glucocorticoid receptor (GR), a steroid hormone-activated transcription factor that is protective in the bladder. Angiopoietin-like 4 (ANGPTL4), a protective protein in the bladder, is transcriptionally regulated by GR and is decreased following arsenic exposure. This proposal aims to investigate how endocrine disruption contributes to changes in the urothelium that eventually lead to bladder cancer. I have hypothesized that chronic dysregulation of GR-mediated transactivation of ANGPTL4 disrupts normal physiological processes of the urothelium. I will address this hypothesis by (1) determining the effects of arsenic exposure on ANGPTL4 transcriptional regulation, (2) evaluating the effects of arsenic exposure on GR transactivation, and (3) observing how chronic arsenic exposure promotes cellular transformation due to disruption of GR transcriptional control of ANGPTL4. Further, I will evaluate GR and ANGPTL4 in tissues from young and old mice to validate the results of my findings. A top research priority at the NIA is to characterize age-related alterations in human physiology. It is well established that complex changes occur in the endocrine system of aging individuals. This study explores the effects of glucocorticoid disruption in the bladder for the first-time. Discoveries from these efforts will contribute to the characterization of bladder carcinogenesis as well as the understanding of other age-related conditions linked to alterations of the endocrine system, such as diabetes, immunosuppression, and neurological and behavioral changes.

描述（由申请人提供）：内分泌系统的改变在老年人群中得到了很好的证实。出现的情况包括糖尿病、甲状腺并发症、骨质疏松症、心血管事件和癌症。砷等重金属是已知的内分泌干扰物，通过饮用水长期接触与老龄人口特有的一系列慢性疾病有关，包括膀胱癌。膀胱癌（BlCa）是一种老年人的疾病，平均诊断年龄为73岁。BlCa是所有实体瘤中复发率最高的肿瘤之一，治疗过程对生活质量有显著影响。20%的患者在手术切除后乳头状肿瘤复发，需要经常监测。此外，患有肌肉浸润性疾病的患者在根治性膀胱切除术后7至8个月会出现盆腔复发。BlCa具有病态的疾病过程，每年花费美国30亿美元。此外，大多数因BlCa而丧生的患者都接受了最终失败的治愈性治疗。对BlCa的病理生理学的了解不足导致缺乏有效的治疗，也使得难以制定预防措施以最终促进健康老龄化。这一点很重要，因为在不到50年的时间里，超过25%的美国人口将超过65岁。BlCa最常见的是在一生中长期暴露于环境风险因素，如砷。砷调节糖皮质激素受体（GR），一种类固醇激素激活的转录因子，在膀胱中具有保护作用。血管生成素样4（ANGPTL4）是膀胱中的一种保护性蛋白，受GR的转录调节，并在砷暴露后降低。该提案旨在研究内分泌干扰如何导致最终导致膀胱癌的尿道变化。我假设GR介导的ANGPTL4反式激活的慢性失调破坏了泌尿系统的正常生理过程。我将通过（1）确定砷暴露对ANGPTL4转录调控的影响，（2）评估砷暴露对GR反式激活的影响，以及（3）观察慢性砷暴露如何由于ANGPTL4的GR转录控制的破坏而促进细胞转化来解决这一假设。此外，我将评估年轻和老年小鼠组织中的GR和ANGPTL4，以验证我的研究结果。NIA的首要研究重点是描述人类生理学中与年龄相关的变化。众所周知，老年人的内分泌系统会发生复杂的变化。本研究首次探讨了糖皮质激素干扰膀胱的影响。这些努力的发现将有助于 膀胱癌发生的特征以及与内分泌系统改变相关的其他年龄相关疾病的理解，如糖尿病，免疫抑制，神经和行为变化。